semaglutide age limit slows epigenetic aging in a randomized trial of HIV-associated lipohypertrophy glp 1 age limit Starting

Clinical research has shown that it significantly reduces liver enzyme levels in patients with non-alcoholic fatty liver disease

Semaglutide and GLP-1 Agonists: Forensic and Medicolegal Implications

The reasons are disputed

The medication may be taken long-term, provided it remains effective and is well tolerated

Currently, there are no active clinical trials specifically testing GLP-1 medications as a treatment for the disorder, according to ClinicalTrials.gov

Elevated IgE antibody levels were noted in around of 80% AD patients, and IgE specific for common inhalant and food allergens were also detected in most patients (144)